These increased interactions point to increased cytotoxicity of the T cells against the tumor cells following KRAS-G12C inhibition, suggesting that the neighborhood of the T/DC community was likely to be able to support the effector function of the CD8+ T cells. This evidence concerns the gene KRAS and neoplasm.